Table 3 Responses in terms of HHFNC guidelines, options for respiratory support and application of supportive therapy on the wards
Working in hospitals with HDU (n = 164, %) | Working in hospitals with no HDU (n = 54, %) | p-value | |
|---|---|---|---|
Decisions to start HHFNC by Paediatricians, n (%) | 60 (36.6) | 38 (70.3) | .0001 |
Availability of guidelines for HHFNC, n (%) | 127 (77.4) | 27 (50) | .0001 |
Proportion of patients using HHFNC on the ward, n (%) | |||
< 1% | 21 (12.8) | 14 (6) | .17 |
1–5% | 47 (28.6) | 22 (40.7) | .12 |
6–10% | 34 (20.7) | 1 (1.8) | .001 |
11–20% | 12 (7.3) | 1 (1.8) | .14 |
> 20% | 2 (1.2) | 9 (16.7) | .0001 |
HHFNC not used on my ward | 9 (5.5) | 6 (11.1) | .16 |
Don’t know | 39 (23.7) | 1 (1.8) | .0001 |
Available options for respiratory support on the ward (including HDU), n (%) | |||
Low Flow O2 | 164 (100) | 54 (100) | N/A |
HHFNC | 155 (95) | 47 (87) | .067 |
CPAP and/or BLPAP | 152 (92.7)a | 15 (27.7)b | .05 |
Established LTV | 111 (67.7)c | 0 | |
Supportive Therapy | |||
Aerosol therapy, n (%) | |||
MDI therapy without stopping HHFNC | 13 (7.9) | 4 (7.4) | NS |
MDI therapy, HHFNC is temporarily stopped | 12 (7.3) | 4 (7.4) | NS |
Nebulised therapy without stopping HHFNC | 101 (61.6) | 31 (57.4) | .58 |
Nebulised therapy, HHFNC is temporarily stopped | 5 (3) | 0 | |
I don’t know | 15 (9.1) | 7 (12.9) | .40 |
NGT insertion, n (%) | |||
Always | 26 (15.8) | 6 (11.1) | .38 |
Most of the times | 84 (51.2) | 22 (40.7) | .22 |
Sometimes | 23 (14) | 11 (20.3) | .67 |
Rarely/Never | 7 (4) | 4 (7.4) | |
Feeding while on HHFNC, n (%) | |||
Strictly NBM | 5 (3) | 6 (11.1) | .018 |
May start NG/NJ feed | 108 (69.5) | 24 (46.2) | .002 |
May start oral feed | 17 (10.3) | 12 (22.2) | .02 |
Sedationd, n (%) | |||
Never | 74 (45.1) | 33 (61.1) | .04 |
Rarely, sometimes | 65 (39.6) | 10 (18.5) | .005 |
Most of the times | 3 (1.8) | 0 | |
Always | 0 | 0 | |